Stay updated on Pembrolizumab Combo in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab Combo in mCRPC Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.6.5 is now shown on the page, replacing Revision: v3.6.4. This marks a minor update to the page content/version of the study record.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page’s revision tag was updated to v3.6.4, replacing the previous v3.6.3, indicating a patch-level update to the page’s documentation.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedRevision v3.6.3 was added and v3.6.0 was removed in the study's documents section, updating the referenced protocol/SAP version for the trial record.SummaryDifference0.0%

- Check62 days agoChange DetectedThe study details page now signals that recruitment is closed, and new help/navigation sections were added or revised (How to Read a Study Record, Common Questions, How to Join a Study) along with an updated Intervention/Treatment heading; a new revision version (v3.6.0) is shown.SummaryDifference0.1%

- Check69 days agoChange DetectedThe revision label on the page footer updated from v3.5.4 to v3.5.5, indicating a deployment update; it represents a backend update with no visible edits to study information.SummaryDifference0.0%

- Check90 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4. This signals an updated version of the page content for the study record.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in mCRPC Clinical Trial page.